The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Takeda
Research Funding - AstraZeneca (Inst)

Combination of niraparib and bevacizumab versus niraparib alone as treatment of recurrent platinum-sensitive ovarian cancer: A randomized controlled chemotherapy-free study—NSGO-AVANOVA2/ENGOT-OV24.
 
Mansoor Raza Mirza
Leadership - Karyopharm Therapeutics; SeraCare
Stock and Other Ownership Interests - Karyopharm Therapeutics; SeraCare
Honoraria - Advaxis; AstraZeneca; Cerulean Pharma; Clovis Oncology; Novocure; Pfizer; Roche; tesaro
Consulting or Advisory Role - AstraZeneca; BioCad; Cerulean Pharma; Clovis Oncology; Genmab; Karyopharm Therapeutics; Novocure; Pfizer; Tesaro
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Pfizer (Inst); Tesaro (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Karyopharm Therapeutics; Pfizer; Roche; SeraCare; Tesaro
 
Elisabeth Avall-Lundqvist
No Relationships to Disclose
 
Michael J. Birrer
Consulting or Advisory Role - Acceleron Pharma; AstraZeneca; Clovis Oncology; Immunogen; Immunogen; Merrimack; Oxigene; Roche/Genentech; Sanofi; Tesaro; Threshold Pharmaceuticals
 
Rene dePont Christensen
No Relationships to Disclose
 
Gitte-Bettina Nyvang
No Relationships to Disclose
 
Susanne Malander
No Relationships to Disclose
 
Maarit Anttila
Consulting or Advisory Role - AstraZeneca; Tesaro
Travel, Accommodations, Expenses - Roche
 
Theresa Louise Werner
Research Funding - AbbVie (Inst); AstraZeneca (Inst); Clovis Oncology (Inst); Mirati Therapeutics (Inst); Roche/Genentech (Inst); Tesaro (Inst)
 
Bente Lund
No Relationships to Disclose
 
Gabriel Lindahl
No Relationships to Disclose
 
Sakari Hietanen
Consulting or Advisory Role - AstraZeneca; Tesaro
Travel, Accommodations, Expenses - Roche Pharma AG
 
Ulla Peen
No Relationships to Disclose
 
Maria Dimoula
No Relationships to Disclose
 
Henrik Roed
No Relationships to Disclose
 
Anja Ør Knudsen
No Relationships to Disclose
 
Louisa Boufercha
No Relationships to Disclose
 
Synnove Staff
No Relationships to Disclose
 
Anders Krog Vistisen
No Relationships to Disclose
 
Line Bjørge
No Relationships to Disclose
 
Johanna Unelma Maenpaa
No Relationships to Disclose